Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Joshi

Showing results (371-380 of 455) with videos related to

Pageof 46
Sort By:
Oncotarget|April 2, 2021
Molecular characterization of lung squamous cell carcinoma tumors reveals therapeutically relevant alterationsAsim Joshi, Rohit Mishra, Sanket Desai, et al.
Archives of Surgery (Chicago, Ill. : 1960)|April 21, 2010
Progressive mucosal injury in patients with gastroesophageal reflux disease and increasing peripheral blood eosinophil countsFarzaneh Banki, Patrick Flanagan, Joerg Zehetner, et al.
Nano Today|November 25, 2014
Nanoparticles for cancer imaging: The good, the bad, and the promiseSandra Chapman, Marina Dobrovolskaia, Keyvan Farahani, et al.
Ecancermedicalscience|June 10, 2022
Outcomes of Ewing sarcoma in adults over 40 years of age from a low-middle income countryGoutam Panda, Arun Chandrasekharan, Shasanka Das, et al.
Ecancermedicalscience|December 7, 2020
Multidisciplinary brain metastasis clinic: is it effective and worthwhile?Annu Rajpurohit, Nilendu Purandare, Aliasgar Moiyadi, et al.
Histopathology|September 29, 2021
A comparative study of AJCC and the modified staging system in pT2/pT3 penile squamous cell carcinoma - a validation on an external data setAkash P Sali, Gagan Prakash, Stênio de Cássio Zequi, et al.
Urologic Oncology|February 12, 2021
Locoregional recurrence after cystectomy in muscle invasive bladder cancer: Implications for adjuvant radiotherapyVedang Murthy, Ganesh Bakshi, Jifmi Jose Manjali, et al.
Lung India : Official Organ of Indian Chest Society|January 11, 2018
Efficacy of gefitinib in epidermal growth factor receptor-activating mutation-positive nonsmall cell lung cancer: Does exon 19 deletion differ from exon 21 mutation?Amit Joshi, Vijay Patil, Vanita Noronha, et al.
Ecancermedicalscience|November 7, 2017
Impact of exon 19 versus exon 21 EGFR-activating mutation on outcomes with upfront pemetrexed-carboplatin chemotherapyVanita Noronha, Vijay Patil, Amit Joshi, et al.
Indian Journal of Cancer|August 8, 2018
Kidney cancer demographics and outcome data from 2013 at a tertiary cancer hospital in IndiaAmit Joshi, Amitesh Anand, Kumar Prabhash, et al.
Pageof 46

Showing results (371-380 of 455) with videos related to

Sort By:
Pageof 46
Oncotarget|April 2, 2021
Molecular characterization of lung squamous cell carcinoma tumors reveals therapeutically relevant alterationsAsim Joshi, Rohit Mishra, Sanket Desai, et al.
Archives of Surgery (Chicago, Ill. : 1960)|April 21, 2010
Progressive mucosal injury in patients with gastroesophageal reflux disease and increasing peripheral blood eosinophil countsFarzaneh Banki, Patrick Flanagan, Joerg Zehetner, et al.
Nano Today|November 25, 2014
Nanoparticles for cancer imaging: The good, the bad, and the promiseSandra Chapman, Marina Dobrovolskaia, Keyvan Farahani, et al.
Ecancermedicalscience|June 10, 2022
Outcomes of Ewing sarcoma in adults over 40 years of age from a low-middle income countryGoutam Panda, Arun Chandrasekharan, Shasanka Das, et al.
Ecancermedicalscience|December 7, 2020
Multidisciplinary brain metastasis clinic: is it effective and worthwhile?Annu Rajpurohit, Nilendu Purandare, Aliasgar Moiyadi, et al.
Histopathology|September 29, 2021
A comparative study of AJCC and the modified staging system in pT2/pT3 penile squamous cell carcinoma - a validation on an external data setAkash P Sali, Gagan Prakash, Stênio de Cássio Zequi, et al.
Urologic Oncology|February 12, 2021
Locoregional recurrence after cystectomy in muscle invasive bladder cancer: Implications for adjuvant radiotherapyVedang Murthy, Ganesh Bakshi, Jifmi Jose Manjali, et al.
Lung India : Official Organ of Indian Chest Society|January 11, 2018
Efficacy of gefitinib in epidermal growth factor receptor-activating mutation-positive nonsmall cell lung cancer: Does exon 19 deletion differ from exon 21 mutation?Amit Joshi, Vijay Patil, Vanita Noronha, et al.
Ecancermedicalscience|November 7, 2017
Impact of exon 19 versus exon 21 EGFR-activating mutation on outcomes with upfront pemetrexed-carboplatin chemotherapyVanita Noronha, Vijay Patil, Amit Joshi, et al.
Indian Journal of Cancer|August 8, 2018
Kidney cancer demographics and outcome data from 2013 at a tertiary cancer hospital in IndiaAmit Joshi, Amitesh Anand, Kumar Prabhash, et al.
Pageof 46